The future of drug discovery: Using AI to optimise the hit-to-lead process
Drug Discovery World
AUGUST 20, 2024
Mirit Eldor , Managing Director, Life Sciences Solutions, Elsevier, looks at how artificial intelligence (AI) can improve the hit-to-lead process for small molecules. Research shows that companies could shorten this cycle by up to 30 months 2 over the course of the small molecule drug discovery process by applying AI.
Let's personalize your content